RNA-Seq Blog Transcriptome Research & Industry News
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many patients become resistant to treatment. ...
Read More »RNA-Seq helps to explain why some triple-negative breast cancers are resistant to chemotherapy
